WEST PHARMACEUTICAL SERVICES, INC. (WST) Shareholders’ equity 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.2BFY2025 · since FY2016: $1.1B → $3.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2B | +18.4% |
| FY2024 | $2.7B | -6.9% |
| FY2023 | $2.9B | +7.3% |
| FY2022 | $2.7B | +15.0% |
| FY2021 | $2.3B | +25.9% |
| FY2020 | $1.9B | +17.9% |
| FY2019 | $1.6B | +12.7% |
| FY2018 | $1.4B | +9.1% |
| FY2017 | $1.3B | +14.5% |
| FY2016 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice